Want to see AU:CU6 full AI Analyst Report?
Clarity Pharmaceuticals Ltd. (CU6) Income Statement
Clarity Pharmaceuticals Ltd. Income Statement
Last quarter (Q4 2026), Clarity Pharmaceuticals Ltd.'s total revenue was $0.00, a decrease of 100.00% from the same quarter last year. In Q4, Clarity Pharmaceuticals Ltd.'s net income was $-51.61M. See Clarity Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| $ 0.00 | $ 9.46M | $ 11.51M | $ 9.80M | $ 6.46M | |
| $ -283.53K | $ 9.46M | $ 11.51M | $ 9.70M | $ 6.41M | |
| $ 118.62M | $ 78.56M | $ 56.31M | $ 36.06M | $ 29.59M | |
| Depreciation and Amortization | $ 283.53K | $ 185.08K | $ 153.07K | $ 100.51K | $ 46.25K |
| $ -118.62M | $ -68.91M | $ -44.65M | $ -34.20M | $ -30.15M | |
| $ -118.91M | $ -69.09M | $ -44.80M | $ -36.16M | $ -17.05M | |
| $ 2.10M | $ 5.22M | $ 2.77M | $ 1.86M | $ -6.69M | |
| $ -116.81M | $ -63.88M | $ -42.03M | $ -24.50M | $ -23.74M | |
| $ -107.14M | $ -64.30M | $ -42.32M | $ -24.60M | $ -23.75M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.29 | $ -0.20 | $ -0.15 | $ -0.09 | $ -0.10 |
| Diluted EPS | $ -0.29 | $ -0.20 | $ -0.15 | $ -0.09 | $ -0.10 |
| Weighted Average Shares Outstanding | 368.03M | 319.20M | 273.16M | 260.41M | 248.47M |
| Weighted Average Shares Outstanding (Diluted) | 368.03M | 319.20M | 273.16M | 260.41M | 248.47M |
Currency in AUD